Skip to main content
TipRanks
Go Ultimate75% OFF

Myomo (MYO) Stock Price & Analysis

593 Followers

MYO Stock Chart & Stats

$1.21-$0.04(-3.20%)
At close: 4:00 PM EST
$1.25$1.5$1.75Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$1.20 - $1.26
52-Week Range
$0.61 - $1.89
Previous Close
$1.25
Volume
N/A
Average Volume (3M)
243.68K
Market Cap
$50.93M
Enterprise Value
$77.43M
Total Cash (Recent Filing)
$11.95M
Total Debt (Recent Filing)
$21.41M
Price to Earnings (P/E)
―
Beta
1.55
Next Earnings
Mar 10, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue And Order Growth

Record revenue, higher orders, and increased MyoPro unit volume indicate expanding commercial adoption. Sustained growth can improve operating leverage, strengthen referral relationships, and build a larger installed base that supports future recurring demand.

Gross Margin And Operating Leverage

Strong gross margins and slower expense growth demonstrate improving business efficiency as volume scales. If maintained, this operating leverage can reduce losses, support reinvestment in commercial expansion, and bring the company closer to sustainable profitability.

Expanded Payer Access And Referral Channels

Broader payer access and a growing share of recurring referral sources can improve authorization rates and make demand less dependent on individual direct-to-patient leads. These developments strengthen the commercial infrastructure supporting multi-quarter growth.

Bears Say

Weak Balance Sheet And Rising Leverage

The sharply reduced equity cushion and higher leverage leave Myomo more exposed to operating setbacks and financing requirements. A pressured capital structure can constrain investment flexibility and make it harder to absorb continued losses before profitability improves.

Negative Cash Generation And Ongoing Losses

The business is not yet self-funding because operating and free cash flow remain materially negative, while losses continue. Even with improved burn, ongoing cash consumption can require external capital and limit the resources available for growth initiatives.

Uneven Patient-pipeline Efficiency

Lower pipeline additions and weaker advertising conversion could slow future device deliveries if referral growth does not offset the shortfall. This makes revenue expansion more dependent on improving lead quality, sales execution, and recurring referral productivity.

Myomo News

MYO FAQ

What was Myomo’s price range in the past 12 months?
Myomo lowest stock price was $0.61 and its highest was $1.89 in the past 12 months.
What is Myomo’s market cap?
Myomo’s market cap is $50.93M.
When is Myomo’s upcoming earnings report date?
Myomo’s next earnings report is estimated for Mar 10, 2027 (not yet confirmed), which is in 117 days.
How were Myomo’s earnings last quarter?
Myomo released its earnings results on Nov 09, 2026. The company reported -$0.1 earnings per share for the quarter, missing the consensus estimate of -$0.078 by -$0.022.
Is Myomo overvalued?
According to Wall Street analysts Myomo’s price is currently Undervalued.
Does Myomo pay dividends?
Myomo does not currently pay dividends.
What is Myomo’s EPS estimate?
Myomo’s EPS estimate is -0.06.
How many shares outstanding does Myomo have?
Myomo has 40,099,174 shares outstanding.
What happened to Myomo’s price movement after its last earnings report?
Myomo reported an EPS of -$0.1 in its last earnings report, missing expectations of -$0.078. Following the earnings report the stock price went down -9.286%.
Which hedge fund is a major shareholder of Myomo?
Hedge funds hold Myomo shares: the largest hedge-fund position in Myomo is 71,887,960 shares, and hedge funds decreased their holdings by 1.5M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology